Blood & Marrow Transplant
The Blood & Marrow Transplant program at The University of Kansas Cancer Center treats many different blood (“hematologic”) cancers and disorders. Our nationally recognized program offers a full spectrum of innovative patient-centered treatment options that allow our patients and families to achieve the best possible outcomes.
Blood and marrow transplantation is a standard treatment option for a variety of malignant and non-malignant blood disorders including leukemia, lymphoma, multiple myeloma, myelodysplastic syndromes and certain solid tumors.
Types of Transplant
A transplant of bone marrow or blood stem cells is similar to a blood transfusion. It uses high doses of chemotherapy, radiation or both to destroy cancer cells in your body. It is followed by an infusion of stem cells from you or your donor.
There are several types of blood and marrow transplant -- also referred to as “stem cell transplant,” which depend on the source of the stem cells used and who serves as the donor.
Autologous
When the stem cells come from your own blood or bone marrow, it is called an autologous transplant. The source of stem cells for an autologous transplant is either bone marrow or peripheral blood.
Allogeneic
When the stem cells come from another person, it is called an allogeneic transplant. The donor may be a relative or a complete stranger. The important thing is that the donor's immune system markers are closely matched to yours.
If the donor is a relative, the transplant is called a related donor transplant. If the donor is unrelated, the transplant is called an unrelated donor transplant.
Stem cells for an allogeneic transplant can be harvested with traditional methods, using bone marrow or peripheral blood stem cells. An additional source of stem cells can be found in the blood inside a newborn's umbilical cord.
We perform blood and marrow transplants for various diseases, including:
- Leukemia
- Acute myelogenous leukemia
- Acute lymphoblastic leukemia
- Chronic lymphocytic leukemia
- Chronic myelogenous leukemia
- Lymphoma
- Burkitt's lymphoma
- Hodgkin lymphoma (“Hodgkin’s disease”)
- Mantle Cell lymphoma
- Non-Hodgkin lymphoma
- Multiple myeloma
- Myelodysplastic syndromes
- Myeloproliferative disorders
Other blood disorders and solid tumors we treat include:
- Amyloidosis
- Aplastic anemia
- Ewing’s sarcoma
- Renal cell carcinoma
- Severe combined immune deficiency (SCID)
- Testicular/germ cell tumors
- Waldenstrom's macroglobulinemia
To Make an Appointment:
Call: 913.588.1227
Toll Free Call: 800.332.6048
Referring Physicians:
Call: 913.588.5862
Toll Free Call: 877.588.5862
Why You Should Choose The University of Kansas Cancer Center
Region's First Accredited Program
The University of Kansas Hospital established its Blood and Marrow Transplant (BMT) program in 1977. It was the first program in the region accredited by the Foundation for Accreditation of Cell Therapy. We have four board-certified doctors specializing in BMT and are dedicated to improving treatment options and providing transplant patients with the best possible care.
To improve services and expand treatment options, the hospital's BMT program and Kansas City Cancer Center began collaborating in July 2007. Today, we are the region's largest BMT program.
Highly trained medical specialists provide blood and marrow transplants for adult patients. Our multidisciplinary approach and the combined experience of our transplant team ensure that you'll receive the highest level of care.
Our BMT program has been Medicare-approved since 1977, and we have been a member of the National Marrow Donor Program since 1995. In 2010, we became a bone marrow collection site for the National Marrow Donor Program.
We take a personal approach with you, your family and your health care providers. Every team member is dedicated to providing cutting-edge treatment options and compassionate care to meet your needs.
We are part of many national clinical trials on cancer treatment. So, you benefit from our staff’s exposure to the latest options. You also may be able to take part in a clinical trial related to blood and marrow transplant during your treatment.